Machine learning
A new blood test developed by AOA Dx has shown unprecedented accuracy in detecting ovarian cancer in its early stages, with a potential to significantly improve patient care and outcomes. The test uses machine learning to recognize patterns in lipids and proteins shed into the bloodstream by cancer cells, offering
Machine learning
Researchers have made a groundbreaking discovery in the development of a blood test that can accurately detect ovarian cancer at its earliest stages, potentially transforming the way the disease is diagnosed and treated. The innovative test, created by AOA Dx, uses machine learning to identify two distinct blood markers in
Prostate cancer
As President Joe Biden's high-grade prostate cancer advances to stage 4, with cancer spread to the bone, medical experts are raising questions about the effectiveness of annual physicals and PSA tests in detecting cancer in senior citizens. Given Biden's age, medical guidelines do not recommend routine
Prostate cancer
Joe Biden's team has clarified that the 82-year-old had never been diagnosed with prostate cancer before last week, contradicting earlier reports. According to a spokesperson, while Biden had undergone a blood test for prostate cancer 11 years ago in 2014, he had never received a diagnosis of the
Prostate cancer
Former United States President Joe Biden had not been diagnosed with prostate cancer before last week, with his last known blood test dating back to 2014, according to his office. Critics, including current President Donald Trump, have raised questions about the timing of the diagnosis, suggesting that Biden might have
Prostate cancer
Joe Biden's cancer diagnosis, announced over the weekend, has sparked debate about the late identification of an aggressive form of prostate cancer and the importance of screening, particularly after the age of 70. The 82-year-old former president's office confirmed that he had not had a blood
Prostate cancer
Former President Biden's recently diagnosed aggressive prostate cancer, which has spread to his bones, has reignited the debate about who should receive annual screenings for signs of the disease. Prostate cancer, the second most common cause of cancer deaths for men, kills 35,000 annually. While some experts
Diseases
The US Food and Drug Administration (FDA) has cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer's disease. The Lumipulse G pTau217/b-Amyloid 1-42 Plasma Ratio, developed by Fujirebio Diagnostics, Inc., measures two proteins found in human plasma and calculates
Diseases
The promise of diagnosing illnesses with small amounts of blood, saliva, or urine has gained significant attention in recent years, particularly with the emergence of companies like Haemanthus. However, the science behind this claim is a far cry from the revolutionary promise of Theranos, a biotech company that was valued
Diseases
The Food and Drug Administration (FDA) has green-lit a blood test called Lumipulse to detect plaques in the brain associated with Alzheimer's disease. This non-invasive test measures two proteins found in plasma to determine whether a patient has amyloid plaques in the brain, a hallmark of Alzheimer'
Diseases
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Prevencio's HART CADhs test, a blood test that uses artificial intelligence to detect obstructive coronary artery disease (CAD) through a simple, non-invasive blood draw. This designation recognizes HART CADhs as an innovative technology that
Blood tests
Healic, a pioneer in transformative healthcare solutions, has launched its first in-society medical room at ATS Advantage in Indirapuram, India. This cutting-edge initiative brings quality healthcare directly to residents' doorsteps, providing accessibility, convenience, and personalized care. With a wide range of services including regular checkups, physiotherapy, and home nursing
